Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 5Head & Neck 4Genitourinary 3Lymphoid 2Gastrointestinal 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Other 1CNS 1Breast 1

Conditions

Obesity 1Breast Neoplasms 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rosiglitazone × Other × Clear all
NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
25 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡